Some portion of intranasally administered peptides may reach the brain through the olfactory pathway, bypassing the blood-brain barrier that limits systemic delivery to CNS tissues
Medicare Part D claims for Ozempic, Rybelsus, Trulicity, and Mounjaro increased from 1.4 million in 2018 to 8.7 million in 2022 (Figure 1)
However, no large-scale randomized trials have specifically studied this combination in weight loss patients, so absolute safety confirmation remains limited
That realization prompted a letter from Allison, a biostatistician at the University of Alabama at Birmingham which, in full disclosure, receives funding from the National Restaurant Association and his colleagues
The quality of your solvent directly affects the quality of your reconstituted peptide
This can increase the risk of inconsistent dosing, unexpected side effects, or reduced effectiveness